Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Martin

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
Rheumatology (Oxford, England)|August 17, 2023
Health-related quality of life, remission and low lupus disease activity state in patients with systemic lupus erythematosusThomas Thibault, Abdessamad Rajillah, Abderrahmane Bourredjem, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 28, 2016
Brief Report: Spatial Heterogeneity of Systemic Sclerosis in France: High Prevalence in the Northeast RegionAlain Meyer, Hélène Chifflot, Emmanuel Chatelus, et al.
Scientific Reports|January 26, 2019
BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivoCédric Schleiss, Wassila Ilias, Ouria Tahar, et al.
Joint Bone Spine|October 5, 2015
Anti-pseudo-PCNA type 1 (anti-SG2NA) pattern: Track down Cancer, not SLEAurélien Guffroy, Alina Dima, Benoit Nespola, et al.
Rheumatology (Oxford, England)|January 24, 2026
Comparison of disease severity and activity between juvenile- and adult-onset dermatomyositis: a multicenter cohort studyAgathe Sinnaeve, Brigitte Bader-Meunier, Anne Mirguet, et al.
Annals of the Rheumatic Diseases|February 24, 2018
Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's diseaseCem Gabay, Bruno Fautrel, Jürgen Rech, et al.
Arthritis Research & Therapy|July 14, 2021
Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in FranceRenaud Felten, Marc Scherlinger, Aurélien Guffroy, et al.
Rheumatology (Oxford, England)|January 1, 2019
Predictors of fatigue and severe fatigue in a large international cohort of patients with systemic lupus erythematosus and a systematic review of the literatureLaurent Arnaud, Pierre Edouard Gavand, Rheinardt Voll, et al.
Annals of the Rheumatic Diseases|March 6, 2026
Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case seriesMarc Scherlinger, Yannick Dieudonné, Stéphane Hilliquin, et al.
JCI Insight|March 9, 2018
Impaired TLR9 responses in B cells from patients with systemic lupus erythematosusVincent Gies, Jean-Nicolas Schickel, Sophie Jung, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Rheumatology (Oxford, England)|August 17, 2023
Health-related quality of life, remission and low lupus disease activity state in patients with systemic lupus erythematosusThomas Thibault, Abdessamad Rajillah, Abderrahmane Bourredjem, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 28, 2016
Brief Report: Spatial Heterogeneity of Systemic Sclerosis in France: High Prevalence in the Northeast RegionAlain Meyer, Hélène Chifflot, Emmanuel Chatelus, et al.
Scientific Reports|January 26, 2019
BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivoCédric Schleiss, Wassila Ilias, Ouria Tahar, et al.
Joint Bone Spine|October 5, 2015
Anti-pseudo-PCNA type 1 (anti-SG2NA) pattern: Track down Cancer, not SLEAurélien Guffroy, Alina Dima, Benoit Nespola, et al.
Rheumatology (Oxford, England)|January 24, 2026
Comparison of disease severity and activity between juvenile- and adult-onset dermatomyositis: a multicenter cohort studyAgathe Sinnaeve, Brigitte Bader-Meunier, Anne Mirguet, et al.
Annals of the Rheumatic Diseases|February 24, 2018
Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's diseaseCem Gabay, Bruno Fautrel, Jürgen Rech, et al.
Arthritis Research & Therapy|July 14, 2021
Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in FranceRenaud Felten, Marc Scherlinger, Aurélien Guffroy, et al.
Rheumatology (Oxford, England)|January 1, 2019
Predictors of fatigue and severe fatigue in a large international cohort of patients with systemic lupus erythematosus and a systematic review of the literatureLaurent Arnaud, Pierre Edouard Gavand, Rheinardt Voll, et al.
Annals of the Rheumatic Diseases|March 6, 2026
Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case seriesMarc Scherlinger, Yannick Dieudonné, Stéphane Hilliquin, et al.
JCI Insight|March 9, 2018
Impaired TLR9 responses in B cells from patients with systemic lupus erythematosusVincent Gies, Jean-Nicolas Schickel, Sophie Jung, et al.
Pageof 15